Michael Hayden

Michael Hayden

Fundador en 89BIO, INC. .

Fortuna: 9 M $ al 30/04/2024

72 años
Health Technology
Commercial Services
Consumer Services

Perfil

Michael R.
Hayden
is the founder of Aspreva Pharmaceuticals Corp.
(founded in 2002) and Centre for Molecular Medicine & Therapeutic (founded in 1992).
He is also the founder of NeuroVir Therapeutic, Inc., Prilenia Therapeutics Development Ltd., and 89bio, Inc. (founded in 2018).
Currently, Dr. Hayden holds positions as an Independent Director at Ionis Pharmaceuticals, Inc. (since 2018), a Non-Executive Director at Oxford Biomedica Plc (since 2021), and a Director-Translational Laboratory at the National University of Singapore.
He is also a Scientific Director at the Canadian Genetics Diseases Network (since 1990), a Director at the Royal Society of Canada (since 1995), a Lead Independent Director at AbCellera Biologics, Inc. (since 2019), a Director & Program Director at the Translational Laboratory in Genetic Medicine, a Venture Advisor at Andera Partners SCA (since 2018), a Professor at the University of British Columbia (since 1983), a Venture Partner at Forbion Capital Partners Management Holding BV (since 2022), and a Member of the American Society of Clinical Investigation (since 1992).
In his former roles, Dr. Hayden served as a Director at Lycera Corp., Many Bright Ideas Technologies, Inc., and the Agency for Science, Technology & Research.
He was also a Director at the Michael Smith Foundation for Health Research (2011-2012), an Independent Director at Aurinia Pharmaceuticals, Inc. (2018-2021), and the Chief Scientific Officer at Teva Pharmaceutical Industries Ltd.
(2013-2017).
Additionally, he was a President & Chief Scientific Officer at GlobaR&D Co., Ltd.
Dr. Hayden obtained his undergraduate and doctorate degrees from the University of Cape Town in 1975 and 1979, respectively.
Dr. Hayden is also the founder of NeuroVir Therapeutic, Inc., Prilenia Therapeutics Development Ltd...

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
01/04/2024 1 441 642 ( 0.49% ) 5 M $ 30/04/2024
01/02/2024 246 430 ( 0.26% ) 2 M $ 30/04/2024
31/03/2024 32 219 ( 0.02% ) 1 M $ 30/04/2024
13/11/2023 39 973 ( 0.04% ) 138 394 $ 30/04/2024

Cargos activos de Michael Hayden

EmpresasCargoInicio
IONIS PHARMACEUTICALS, INC. Director/Miembro de la Junta 24/09/2018
89BIO, INC. Fundador 01/04/2018
ABCELLERA BIOLOGICS INC. Director/Miembro de la Junta 01/10/2019
OXFORD BIOMEDICA PLC Director/Miembro de la Junta 15/07/2021
Consultor / Asesor 01/01/2018
Inversor de Capital Privado 31/03/2022
Fundador 01/10/2018
National University of Singapore Corporate Officer/Principal -
American Society of Clinical Investigation Corporate Officer/Principal 01/01/1992
░░░░░░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ -
Todos los cargos activos de Michael Hayden

Antiguos cargos conocidos de Michael Hayden.

EmpresasCargoFin
░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Michael Hayden.

Formación de Michael Hayden.

University of Cape Town Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Michael Hayden.

Relaciones

100 +

Relaciones de 1er grado

27

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas8
TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Health Technology

IONIS PHARMACEUTICALS, INC.

Health Technology

OXFORD BIOMEDICA PLC

Health Technology

XENON PHARMACEUTICALS INC.

Health Technology

MANY BRIGHT IDEAS TECHNOLOGIES INC.

Health Services

AURINIA PHARMACEUTICALS INC.

Health Technology

ABCELLERA BIOLOGICS INC.

Health Technology

89BIO, INC.

Health Technology

Empresas privadas16

Health Technology

Health Technology

Finance

Commercial Services

Finance

Miscellaneous

Commercial Services

American Society of Clinical Investigation

Commercial Services

Commercial Services

Centre for Molecular Medicine & Therapeutic

Health Technology

Translational Laboratory in Genetic Medicine

Commercial Services

Health Technology

GlobaR&D Co. ,Ltd

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA